Today’s Form D Filing: Biosig Technologies $5.00 million Fundraising. Gregory Cash Released Oct 31 form D

Biotechnology Biosig Technologies, Inc. - Gregory Cash

Biosig Technologies Financing

Biosig Technologies, Inc., Corporation just had published form D announcing $5.00 million equity financing. This is a new filing. Biosig Technologies was able to finance itself with $519,850 so far. That is 10.40% of the fundraising. The total fundraising amount was $5.00 million. The private financing document was filed on 2016-10-31. The reason for the financing was: This represents consideration of $519,850 for the Issuer’s first closing occurring on October 28, 2016.. The fundraising still has about $4.48 million more and is not closed yet. We have to wait more to see if the offering will be fully taken.

Biosig Technologies is based in Minnesota. The company’s business is Biotechnology. The form D was signed by Gregory Cash President and Chief Executive Officer. The company was incorporated in 2011. The filler’s address is: 8441 Wayzata Blvd, Suite 240, Minneapolis, Mn, Minnesota, 55426. Kenneth Londoner is the related person in the form and it has address: 8441 Wayzata Blvd., Suite 240, Minneapolis, Mn, Minnesota, 55426. Link to Biosig Technologies Filing: 000153076616000009.

Analysis of Biosig Technologies Offering

On average, firms in the Biotechnology sector, sell 73.77% of the total offering size. Biosig Technologies sold 10.40% of the offering. The financing is still open. The average fundraising size for companies in the Biotechnology industry is $3.08 million. The offering was 83.12% smaller than the average of $3.08 million. Of course this should not be interpreted as negative. Companies raise funds for different reasons and needs. The minimum investment for this fundraising is set at $15000. If you know more about the reasons for the fundraising, please comment below.

What is Form D? What It Is Used For

Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.

Why Fundraising Reporting Is Good For Biosig Technologies Also

The Form D signed by Gregory Cash might help Biosig Technologies, Inc.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment